Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Debt Ratio (2021 - 2025)

Indivior Pharmaceuticals has reported Debt Ratio over the past 5 years, most recently at 0.27 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.27 for Q4 2025, up 4.97% from a year ago — trailing twelve months through Dec 2025 was 0.27 (up 4.97% YoY), and the annual figure for FY2025 was 0.27, up 4.97%.
  • Debt Ratio for Q4 2025 was 0.27 at Indivior Pharmaceuticals, up from 0.23 in the prior quarter.
  • Over the last five years, Debt Ratio for INDV hit a ceiling of 0.27 in Q4 2025 and a floor of 0.13 in Q4 2021.
  • Median Debt Ratio over the past 5 years was 0.23 (2025), compared with a mean of 0.2.
  • Biggest five-year swings in Debt Ratio: grew 0.63% in 2023 and later surged 85.35% in 2024.
  • Indivior Pharmaceuticals' Debt Ratio stood at 0.13 in 2021, then rose by 2.71% to 0.14 in 2022, then grew by 0.63% to 0.14 in 2023, then soared by 85.35% to 0.25 in 2024, then increased by 4.97% to 0.27 in 2025.
  • The last three reported values for Debt Ratio were 0.27 (Q4 2025), 0.23 (Q3 2025), and 0.22 (Q2 2025) per Business Quant data.